3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Prostatic Neoplasms
6
Lymphoma
3
Lung Neoplasms
3
Carcinoma, Hepatocellular
3
Squamous Cell Carcinoma of Head and Neck
2
Small Cell Lung Carcinoma
2
Rectal Neoplasms
2
Melanoma
2
Lymphoma, Non-Hodgkin
2
Lymphoma, Large B-Cell, Diffuse
2
Head and Neck Neoplasms
2
Gastrointestinal Neoplasms
2
Colonic Neoplasms
2
Burkitt Lymphoma
2
Breast Neoplasms
2
Vasculitis
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Triple Negative Breast Neoplasms
1
Stomach Neoplasms
1
Smoking Cessation
1
Recurrence
1
Pancreatic Neoplasms
1
Osteomyelitis
1
Nose Neoplasms
1
Neoplasms
1
Neoplasm Metastasis
1
Multiple Pulmonary Nodules
1
Metastatic Solid Tumors
1
Lymphoproliferative Disorders
1
Interventions
Cyclophosphamide
15
romidepsin
9
Whole-Body Irradiation
9
fludarabine phosphate
8
Vincristine
8
Etoposide
8
Doxorubicin
8
Prednisone
7
Peripheral Blood Stem Cell Transplantation
7
Mycophenolic Acid
7
Brentuximab Vedotin
6
10-propargyl-10-deazaaminopterin
6
Rituximab
5
Granulocyte Colony-Stimulating Factor
5
Gemcitabine
5
Cyclosporine
5
denileukin diftitox
4
Nivolumab
4
Lenalidomide
4
mogamulizumab
3
Tacrolimus
3
Methotrexate
3
Immunohistochemistry
3
Gene Expression Profiling
3
Dexamethasone
3
Alemtuzumab
3
selinexor
2
pembrolizumab
2
pegfilgrastim
2
liposomal doxorubicin
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Lymphoma, T-Cell, Peripheral
×
Tomography, X-Ray Computed
×
Clear all
No trials found.